HOME >> BIOLOGY >> NEWS
May: Multiple Sclerosis Awareness Month -- latest research is good news

Montreal, QC -- May is Multiple Sclerosis Month and there is no better way of raising awareness for this unpredictable and often debilitating disease then by highlighting the latest research that might offer hope for the 55 to 75, 000 sufferers across Canada. A new drug under investigation for Multiple Sclerosis (MS) appears to be safe and effective according to studies involving researchers at the Montreal Neurological Institute. The studies, presented this week at the American Academy of Neurologys (AAN) 59th Annual Meeting in Boston, also provide deeper insight into the biology of this complex disease. Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world with approximately 1,000 new cases of MS diagnosed each year. MS is the most common neurological disease affecting young adults in Canada and affects 18% of all Quebecers.

The Phase I and Phase II studies involved people in Canada and the USA with relapsing-remitting MS, in which symptoms flare up and then subside. Treatment with the drug rituximab significantly reduced the number of new brain lesions and the frequency of relapses, times when symptoms of MS flare up.

Rituximab is a therapeutic antibody that selectively targets and depletes a set of immune cells called B-cells by binding to a specific protein on their surface.

"This is the first drug to selectively target B-cells in MS and the significance of its effectiveness is two-fold," says Dr. Amit Bar-Or, neurologist at the Montreal Neurological Institute (MNI) at McGill University, Montreal, Canada and lead investigator in the Phase I study. "Not only might it present a significantly improved therapy for patients with relapsing-remitting MS, but it provides a clearer picture of the role that B-cells play in the disease. Its a particularly exciting time and we think meaningful to advancing treatment options for patients."

The Phase I trial was primarily designed to assess the safety
'"/>

Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
Montreal Neurological Institute and Hospital
2-May-2007


Page: 1 2

Related biology news :

1. Alleviating the burden of Multiple Sclerosis
2. Multiple sclerosis progression linked to immune-cell substance
3. Multiple genes permit closely related fish species to mix and match their color vision
4. Multiple genetic flavors may explain autism
5. Multiple sightings of long-lost woodpecker reported
6. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
7. Brain Awareness Week teaches kids how their brains work
8. Breast Cancer Month story tips from Georgetown University Medical Center
9. National Academies advisory: Feb. 15 program for African-American History Month
10. AAAS decries latest stem cell veto
11. Brain, size and gender surprises in latest fossil tying humans, apes and monkeys

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... BALTIMORE, Md. (PRWEB) , ... October 11, 2017 ... ... for digital pathology, announced today it will be hosting a Webinar titled, “Pathology ... of  Advanced Pathology Associates , on digital pathology adoption best practices and how ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions ... over 5.5 million people each year. Especially those living in larger cities are affected ... based in one of the most pollution-affected countries globally - decided to take action. ...
(Date:10/10/2017)... ... 10, 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, ... The bold new look is part of a transformation to increase awareness, appeal ... growth period. , It will also expand its service offering from its signature gourmet ...
Breaking Biology Technology:
Cached News: